Gabapentin Capsule
Product Images NDC 71335-1269

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

A formula panel showing the calculation for creatinine clearance (CLCr), which involves age, weight, serum creatinine, and a factor adjustment for female patients. The formula is presented as a fraction with age and weight in the numerator and serum creatinine and a constant in the denominator.*

FDA Label Image

Gabapentin Fig1

A line graph comparing mean pain scores over 8 weeks between placebo and Gabapentin 3600 mg/day treatment groups. The x-axis shows weeks from baseline to week 8, while the y-axis indicates mean pain scores from 0 to 10. The graph highlights a 4-week dose titration period followed by a 4-week fixed dose period. Gabapentin shows a decreasing pain score trend compared to placebo.*

FDA Label Image

Gabapentin Fig2

A line graph showing mean pain score over a 7-week period for placebo and two gabapentin doses (1800 mg/day and 2400 mg/day) during a 3-week dose titration and a 4-week fixed dose period. The mean pain score decreases over time for both gabapentin groups compared to placebo.*

FDA Label Image

Gabapentin Fig3

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing results from two studies. Study 1 compares placebo (PBO) with Gabapentin 3600 mg, with response rates of 12% and 29% respectively. Study 2 compares placebo (14%) with Gabapentin 1800 mg (32%) and 2400 mg (34%). Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

A comparative bar chart showing percentage differences across three studies labeled a, b, and c, plotted against daily doses of gabapentin in mg (600, 900, 1200, and 1800 mg). The chart uses different shaded squares to represent each study's data points at various dose levels.*

FDA Label Image

Label Image (Lbl713351269)

Label for Gabapentin 300 mg capsule by Bryant Ranch Prepack. The label includes a comparison to Neurontin 300 mg capsule by Alkem Laboratories Limited. It displays the lot number 1523487, storage temperature instructions of 20-25°C (68-77°F), a warning about dizziness, and a caution to keep drugs out of children's reach. The NDC number 71335-1269 is also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.